SPEC

Laser Diode: Solid state (crystal)
Wavelength: 589nm & 1319nm
Spot size: 1,2,3 mm
Scanner: 5×5 mm, 7×7 mm, 10×10 mm
Fluence: 5 J/cm2 – 60 J/cm2
Size: 50 x 23 x 23 Inches (Height × Width × Depth) (127 x 58.5 x 58.5 cm)
Weight: 187 lbs (85kg)
Consumables: None
Supply voltage: 100-240V
Certification: FDA 510 (k), CE

SIMPLE USER INTERFACE

Usability is one of the fundamentals in the design of ADVATx. We have developed the user interface to be simple, intuitive and easy to operate.

SCANNER HAND PIECE

Single Spot or Fractionated Delivery – Both 589nm and 1319nm are delivered via the same scanner hand piece.

SCANNER PATTERNS

ADVATx scanner deliveries different scan patterns allowing the physician to tailor the delivery of laser energy according to the area being treated. See illustration.

DELIVERY METHOD (589 nm)

In order to minimize the discomfort and unwanted side effects such as purpura, or other damage to surrounding tissue caused by Pulsed Dye Lasers (PDL), ADVATx employs Quasi CW pulsing, delivering individual pulses of energy at a repetition rate of 12 kHz.

As the durations of the individual pulses, as well as the pulse-to-pulse spacings are significantly shorter than the thermal relaxation time of the vessels, the skin perceives the multiple pulses of energy as a single pulse. For example, this means that a 20 ms pulse of energy can be directed at the target, i.e. Veins, without the trauma to the surrounding tissue caused by the significantly larger energy spikes of a PDL.

Simply stated, because of our advanced delivery system, ADVATx allows for all the well-known therapeutic benefits of yellow light, without the undesirable side effects associated with PDL.

It is important to state that the 1319 nm is delivered as continuous wave, allowing for controlled, gradual bulk heating of tissue for optimal fibroblastic proliferation and reduction of sebum production form sebaceous glands.

RE-DEFINING THE GOLD STANDARD FOR FACIAL LASER TECHNOLOGY

With both 589 nm and 1319 nm available via a single spot or scanned pattern, ADVATx allows the physician to customize the treatment of red, blue and purple vascular conditions, acne, acne scars and more with no pain or unwanted side effects such as bruising, purpura or scarring.

To date, over 2,000 patients have been treated with no adverse events reported.

While the wavelengths provided by the ADVATx are well documented for their FDA and CE cleared indications, formal clinical studies employing the ADVATx laser are on-going with some of the top Dermatologists in the world.

ADVATX HAS OVER 15 FDA/CE CLEARED INDICATIONS

The world’s only medical, solid-state laser producing both 589nm and 1319nm wavelengths

FDA 589NM

Melasma
Inflammatory Acne Vulgaris
Port wine stains
Telangectasia – face/legs
Rosacea
Hemangioma
Venous lake
Angiomas
Scars
Striae
Warts
Wrinkles – Periocular/Periorbital
Psoriasis

FDA 1319NM

Fine Lines and Wrinkles
Atrophic Acne Scars
Mild/Moderate Inflammatory Acne

CE 589NM

Telangiectasias
Spider veins, both facial and leg
Rosacea
Hemangiomas
Port wine stains
Venous lakes
Red or hypertrophic scars
Melasma
Hyper pigmentation
Skin rejuvenation

CE 1319NM

Skin rejuvenation
Reduction of acne scars
Reduction in the appearance of pores
Mild and moderate inflammatory acne vulgaris

BEFORE AND AFTER TREATMENTS - ADVALIGHT

TREATMENTS

Name: ADVAtx
Brand: ADVALight

SKIN REJUVENATION

Combining 589nm and 1319nm wavelengths initiates an inflammatory response by targeting superficial vasculature while at the same time causing thermal injury to the papillary dermis, intitiating the body's natural wound healing response, stimulating fibroblast activity and the formation of Type 1 and 3 collagen, resulting in visible improvement to tone and texture.

VASCULAR

The ideal ratio of oxyhemoglobin to melanin absorption of 589nm, coupled with the PulSync delivery system, provides for the ability to safely and effectively treat a broad range of vascular abnormalities without patient downtime.

ACNE

By targeting the acne bacteria itself, the vascular component to active lesions and the underlying oil production by the sebaceous glands, the ADVATx employs a multi-pronged approach to reducing active acne.

MELASMA

By addressing the underlying vascular components with 589nm and the sebaceous gland component with 1319nm, melasma is targeted on multiple fronts. The absorption characteristics and delivery mechanism allow treatment with a low risk of PIH.

RESOLVING SKIN CONDITIONS TO IMPROVE PATIENTS’ QUALITY OF LIFE

Worldwide, millions of people are bothered by the appearance of vascular lesions, melasma, rosacea, acne, wrinkles and scars. These conditions are associated with negative impact on quality of life and may result in psychological morbidity. Laser therapy has proven to be efficient in reducing and resolving many of these unwanted conditions, thereby improving patients’ quality of life.